- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1339EUR$1,500USD£1,164GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1786EUR$2,000USD£1,552GBP
- Report
- July 2025
- 350 Pages
Global
From €4419EUR$4,949USD£3,840GBP
- Report
- June 2025
- 400 Pages
Global
From €4419EUR$4,949USD£3,840GBP
- Report
- April 2025
- 192 Pages
Global
From €4460EUR$4,995USD£3,876GBP
- Report
- August 2025
- 150 Pages
Global
From €4331EUR$4,850USD£3,763GBP
- Report
- November 2025
- 150 Pages
Global
From €5313EUR$5,950USD£4,617GBP
- Report
- July 2025
- 120 Pages
Global
From €5313EUR$5,950USD£4,617GBP
- Report
- March 2026
- 487 Pages
Global
From €5223EUR$5,850USD£4,539GBP
- Report
- March 2026
- 563 Pages
Global
From €5223EUR$5,850USD£4,539GBP
- Report
- February 2026
- 250 Pages
Global
From €4009EUR$4,490USD£3,484GBP
- Report
- November 2025
- 185 Pages
Global
From €4018EUR$4,500USD£3,492GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2490EUR$2,789USD£2,164GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2490EUR$2,789USD£2,164GBP
- Report
- November 2025
- 150 Pages
United States
From €3527EUR$3,950USD£3,065GBP
- Report
- February 2026
- 250 Pages
Global
From €4009EUR$4,490USD£3,484GBP
- Report
- June 2024
- 200 Pages
Global
From €7099EUR$7,950USD£6,169GBP
- Report
- June 2024
- 200 Pages
Global
From €7099EUR$7,950USD£6,169GBP
- Report
- January 2022
- 60 Pages
Global
From €3527EUR$3,950USD£3,065GBP
- Report
- May 2024
- 137 Pages
Global
From €3571EUR$3,999USD£3,103GBP

The Urinary Incontinence Drug market is a subset of the Urological Disorders Drugs market, which includes drugs used to treat a variety of conditions related to the urinary system. Urinary Incontinence Drugs are used to treat the involuntary leakage of urine, which can be caused by a variety of conditions, including overactive bladder, stress incontinence, and urge incontinence. These drugs can be administered orally, topically, or through injections. Commonly used drugs include anticholinergics, beta-3 agonists, and alpha-blockers.
Some of the companies in the Urinary Incontinence Drug market include Allergan, Astellas Pharma, Pfizer, Merck, and Sanofi. Show Less Read more